| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,346 |
14,221 |
$730K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,251 |
3,976 |
$324K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,013 |
2,951 |
$176K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
9,306 |
4,464 |
$108K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,985 |
2,854 |
$95K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,635 |
1,589 |
$50K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,267 |
4,978 |
$30K |
| 92550 |
|
727 |
682 |
$5K |
| 87807 |
|
108 |
106 |
$1K |
| 81003 |
|
955 |
885 |
$1K |
| 81025 |
|
174 |
157 |
$971.83 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
94 |
89 |
$969.76 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
42 |
33 |
$264.22 |
| 99000 |
|
2,732 |
2,663 |
$35.87 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
13 |
12 |
$16.92 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
22 |
13 |
$3.31 |
| A9150 |
Non-prescription drugs |
16 |
15 |
$1.31 |
| 99051 |
|
529 |
435 |
$0.00 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
167 |
141 |
$0.00 |